HIGHLIGHTS
- who: from the Call for New Approaches for Subcellular Delivery of Anti-cancer Drugs Kan Xiong* Broad Institute of MIT and Harvard, Cambridge, USA have published the Article: The Emerging Potential and Perspectives of Induced Pluripotent Stem Cells (iPSCs), in the Journal: (JOURNAL)
SUMMARY
Though grossly similar in their molecular contents, the tumor cells do differ from their healthy counterparts, and anti-cancer therapies take advantage of these differences to selectively interfere with the growth and survival of cancer cells. The essential role of genetics in cancer and the need for rapidly dividing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.